article thumbnail

HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage

DAIC

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104
article thumbnail

CMS Releases Proposed 2025 Medicare Physician Fee Schedule and Hospital OPPS Rule

American College of Cardiology

The Centers for Medicare and Medicaid Services (CMS) has released the proposed 2025 Medicare Physician Fee Schedule (PFS). Of note, the PFS conversion factor has been updated from $33.2875 to $32.3562, a 2.80% cut.

CMS 63
article thumbnail

CMS Releases 2025 Medicare Physician Fee Schedule and Hospital OPPS Final Rules

American College of Cardiology

The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule and the 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgery Center (ASC) final rule on Nov.

CMS 60
article thumbnail

ACC 2025 Medicare Physician Fee Schedule Proposed Rule Calculator Now Available

American College of Cardiology

Work, practice, expense and liability relative value units are updated annually through the Centers for Medicare and Medicaid Services’ Medicare Physician Fee Schedule (PFS) rulemaking.

article thumbnail

ACC 2025 Medicare Physician Fee Schedule Final Rule Calculator Now Available

American College of Cardiology

Work, practice, expense and liability relative value units (RVUs) are updated annually through the Centers for Medicare and Medicaid Services' Medicare Physician Fee Schedule (PFS) rulemaking.

article thumbnail

Proposed 2025 Medicare Physician Fee Schedule Deep Dive

American College of Cardiology

The Centers for Medicare and Medicaid Services (CMS) released the proposed 2025 Medicare Physician Fee Schedule (PFS) on July 10, addressing Medicare payment and quality provisions for physicians in the coming year. Under the proposal, physicians will see a decrease to the conversion factor of 2.80% on Jan.

article thumbnail

Weight Loss Drugs Land Medicare Coverage for Cardiovascular Events

CardiacWire

Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.